Veradermics, Incorporated
MANE
NYSE
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 1.02M | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 5.97M | ||||
| Operating Income | -5.97M | ||||
| Income Before Tax | -5.66M | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -5.66M | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -5.66M | ||||
| EBIT | -5.97M | ||||
| EBITDA | -- | ||||
| EPS Basic | -8.79 | ||||
| Normalized Basic EPS | -4.80 | ||||
| EPS Diluted | -8.79 | ||||
| Normalized Diluted EPS | -4.80 | ||||
| Average Basic Shares Outstanding | 736.90K | ||||
| Average Diluted Shares Outstanding | 736.90K | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||